Written Exposure Therapy and App-Delivered Mindfulness Meditation for PTSD in China: A Pilot Study
1 other identifier
interventional
45
1 country
1
Brief Summary
The goal of this study is to use a pilot RCT to assess the effectiveness of Written Exposure Therapy (WET) and a mindfulness-based app (MBA) for managing PTSD and comorbid insomnia in China. The main questions it aims to answer are:
- Undergo random assignment to one of three groups: WET, WET plus MBA, or MCC.
- Receive clinical interviews for primary outcomes (PTSD symptoms) at baseline, posttreatment, and during follow-ups.
- Provide self-reported data on PTSD symptoms and insomnia severity at multiple time points.
- In the WET plus MBA group, additionally use a mindfulness-based app as part of their treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 11, 2021
CompletedFirst Submitted
Initial submission to the registry
April 23, 2024
CompletedFirst Posted
Study publicly available on registry
May 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2024
CompletedMay 1, 2024
April 1, 2024
2.5 years
April 23, 2024
April 29, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
PTSD symptom severity
The reduction in PTSD symptoms will be measured using the PTSD Symptom Scale, Interview Version for DSM-5 (PSSI-5). This clinician-administered interview assesses the frequency and severity of PTSD symptoms using a 5-point Likert scale ranging from 0 (not at all) to 4 (very much).
Assessed at baseline, immediately post-treatment, and at 3-month follow-up periods.
Secondary Outcomes (1)
Insomnia Severity
Insomnia severity is assessed at baseline, weekly during the 5-week treatment period, and at the immediate post-treatment, and 3-month follow-up assessments.
Study Arms (3)
Written Exposure Therapy (WET)
EXPERIMENTALWritten Exposure Therapy plus mindfulness-based App (WET+MBA)
EXPERIMENTALMinimal Contact Control (MCC)
PLACEBO COMPARATORInterventions
Written Exposure Therapy (WET) is a manualized exposure-based therapy involving five sequential weekly individual sessions. Each session lasts approximately 40 minutes except the first, which is one hour. In the initial session, the therapist explains the treatment rationale and guides the participant to write about their traumatic experience uninterrupted for 30 minutes. Subsequent sessions start with a brief discussion about the previous session's writing, followed by another 30-minute writing session, concluding with a short check-in. There is no homework between sessions.
WET + MBA combines the standard WET protocol with the addition of a mindfulness practice facilitated through a mobile app called "Now Meditation." This app is among the most downloaded mindfulness apps in China, used to help manage symptoms of insomnia commonly comorbid with PTSD. Participants are instructed to engage in daily mindfulness exercises according to the app's "7-Day Basic Meditation" program and continue practicing mindfulness throughout the duration of the therapy. This is intended to supplement the therapeutic effects of WET by providing tools to manage insomnia and potentially enhancing the therapeutic process by fostering greater mindfulness and relaxation.
MCC contains weekly phone calls from a study therapist to monitor their status and provide support as needed, without introducing any specific therapeutic interventions. These calls are brief, generally lasting between 10 to 15 minutes, and are strictly for the purpose of engagement and safety monitoring rather than therapeutic intervention.
Eligibility Criteria
You may qualify if:
- Adult male and female aged between 18-65 years old;
- A diagnosis of PTSD or subthreshold PTSD (PTSD Symptom Scale, Interview Version for DSM-5, PSSI-5);
- If currently taking psychotropic medication, taking a stable one for at least 4 weeks;
- A smartphone owner and no obstacle to the Now Meditation App;
- Scoring 12 or more on Insomnia Severity Index (ISI; the symptoms appear after the diagnosis of full/subthreshold PTSD).
You may not qualify if:
- A diagnosis of bipolar disorder or psychotic disorder;
- Current substance dependence;
- Evidence of a moderate or severe traumatic brain injury (as determined by the obstacle to comprehending the baseline screening questionnaires);
- Serious suicidal ideation (as determined by the Scale for Suicidal Ideation);
- Other psychiatric disorders severe enough to warrant designation as the primary disorder;
- Taking psychotherapy for PTSD currently.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking University
Beijing, Beijing Municipality, 100871, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 23, 2024
First Posted
May 1, 2024
Study Start
November 11, 2021
Primary Completion
May 1, 2024
Study Completion
August 1, 2024
Last Updated
May 1, 2024
Record last verified: 2024-04